Cargando…

Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome

BACKGROUND: The relationship of saliva with plasma protein levels makes saliva an attractive diagnostic tool. Plasma levels of adiponectin and leptin in healthy individuals or diabetes mellitus patients have been previously reported. Nevertheless, salivary levels of these adipocytokines in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanakun, Supanee, Watanabe, Hisashi, Thaweboon, Sroisiri, Izumi, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926677/
https://www.ncbi.nlm.nih.gov/pubmed/24528653
http://dx.doi.org/10.1186/1758-5996-6-19
_version_ 1782304010317856768
author Thanakun, Supanee
Watanabe, Hisashi
Thaweboon, Sroisiri
Izumi, Yuichi
author_facet Thanakun, Supanee
Watanabe, Hisashi
Thaweboon, Sroisiri
Izumi, Yuichi
author_sort Thanakun, Supanee
collection PubMed
description BACKGROUND: The relationship of saliva with plasma protein levels makes saliva an attractive diagnostic tool. Plasma levels of adiponectin and leptin in healthy individuals or diabetes mellitus patients have been previously reported. Nevertheless, salivary levels of these adipocytokines in patients with metabolic syndrome (MS) have never been investigated. This study was aimed to determine adiponectin and leptin levels in saliva and plasma from patients with metabolic syndrome, and evaluate any correlation of these levels with MS. METHODS: Forty-six healthy and 82 MS patients were enrolled. Demographic data and blood biochemistries were recorded. Saliva and plasma adiponectin and leptin levels were analyzed by enzyme-linked immunosorbent assay (ELISA). RESULTS: Adiponectin and leptin were higher in plasma than in saliva (p < .001). Plasma adiponectin was decreased and plasma leptin increased in patients with MS (p < .001). Salivary adiponectin and salivary leptin were not different between healthy subjects and MS patients (p = .619 and p = .523). Correlation between salivary and plasma adiponectin showed significant association (r = .211, p = .018) while salivary and plasma leptin had no correlation (r = -.161, p = .069). Significant correlation was observed between the salivary adiponectin/salivary leptin ratio and plasma adiponectin (r = .371, p < .001), but not with any component of MS. Increased triglyceride and waist circumference were associated with risk of having a low level of plasma adiponectin (OR = 1.009; 95% CI 1.002–1.015 and OR = 1.125; 95% CI 1.029–1.230). For leptin, body mass index and high-density lipoprotein cholesterol (HDL-C) were associated with a high level of plasma leptin (OR = 1.621; 95% CI 1.212–2.168 and OR = .966; 95% CI .938–.996). The OR for MS as predicted by plasma adiponectin was .928 (95% CI .881-.977). CONCLUSIONS: This study showed that salivary adiponectin and leptin do not correlate with MS. Although correlation between salivary and plasma adiponectin was observed, no association with MS was observed. Only plasma adiponectin may be useful for the prediction of MS.
format Online
Article
Text
id pubmed-3926677
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39266772014-02-18 Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome Thanakun, Supanee Watanabe, Hisashi Thaweboon, Sroisiri Izumi, Yuichi Diabetol Metab Syndr Research BACKGROUND: The relationship of saliva with plasma protein levels makes saliva an attractive diagnostic tool. Plasma levels of adiponectin and leptin in healthy individuals or diabetes mellitus patients have been previously reported. Nevertheless, salivary levels of these adipocytokines in patients with metabolic syndrome (MS) have never been investigated. This study was aimed to determine adiponectin and leptin levels in saliva and plasma from patients with metabolic syndrome, and evaluate any correlation of these levels with MS. METHODS: Forty-six healthy and 82 MS patients were enrolled. Demographic data and blood biochemistries were recorded. Saliva and plasma adiponectin and leptin levels were analyzed by enzyme-linked immunosorbent assay (ELISA). RESULTS: Adiponectin and leptin were higher in plasma than in saliva (p < .001). Plasma adiponectin was decreased and plasma leptin increased in patients with MS (p < .001). Salivary adiponectin and salivary leptin were not different between healthy subjects and MS patients (p = .619 and p = .523). Correlation between salivary and plasma adiponectin showed significant association (r = .211, p = .018) while salivary and plasma leptin had no correlation (r = -.161, p = .069). Significant correlation was observed between the salivary adiponectin/salivary leptin ratio and plasma adiponectin (r = .371, p < .001), but not with any component of MS. Increased triglyceride and waist circumference were associated with risk of having a low level of plasma adiponectin (OR = 1.009; 95% CI 1.002–1.015 and OR = 1.125; 95% CI 1.029–1.230). For leptin, body mass index and high-density lipoprotein cholesterol (HDL-C) were associated with a high level of plasma leptin (OR = 1.621; 95% CI 1.212–2.168 and OR = .966; 95% CI .938–.996). The OR for MS as predicted by plasma adiponectin was .928 (95% CI .881-.977). CONCLUSIONS: This study showed that salivary adiponectin and leptin do not correlate with MS. Although correlation between salivary and plasma adiponectin was observed, no association with MS was observed. Only plasma adiponectin may be useful for the prediction of MS. BioMed Central 2014-02-14 /pmc/articles/PMC3926677/ /pubmed/24528653 http://dx.doi.org/10.1186/1758-5996-6-19 Text en Copyright © 2014 Thanakun et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Thanakun, Supanee
Watanabe, Hisashi
Thaweboon, Sroisiri
Izumi, Yuichi
Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
title Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
title_full Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
title_fullStr Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
title_full_unstemmed Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
title_short Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
title_sort comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926677/
https://www.ncbi.nlm.nih.gov/pubmed/24528653
http://dx.doi.org/10.1186/1758-5996-6-19
work_keys_str_mv AT thanakunsupanee comparisonofsalivaryandplasmaadiponectinandleptininpatientswithmetabolicsyndrome
AT watanabehisashi comparisonofsalivaryandplasmaadiponectinandleptininpatientswithmetabolicsyndrome
AT thaweboonsroisiri comparisonofsalivaryandplasmaadiponectinandleptininpatientswithmetabolicsyndrome
AT izumiyuichi comparisonofsalivaryandplasmaadiponectinandleptininpatientswithmetabolicsyndrome